N ew guidelines for preventing and treating high blood pressure have been released by the National Heart, Lung, and Blood Institute's National High Blood Pressure Education Program (NHBPEP). The recently released Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (INC VI, 1997) provides guidance to help busy occupational health nurses translate research findings into clinical practice. The American Association of Occupational Health Nurses continues to be a member and valuable partner of the Coordinating Committee for the NHBPEP. As such, the AAOHN has an important role in the development of these and future guidelines as well as an opportunity to provide influential and practical feedback on their implementation.
The development of guidelines such as the JNC VI report is one of the processes used by the NHLBI to disseminate research results. The JNC VI report serves as a tool to be adapted and implemented in individual situations. The report is not proscriptive. Rather, it recognizes that the responsible clinician's judgment of the individual client's needs remains paramount. As such, it is essential that occupational health nurses incorporate this guidance into professional practice. 
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THE EFFECTS OF HYPERTENSION
Hypertension is defined as systolic blood pressure of ""'140 mm Hg, diastolic blood pressure "",90mm Hg, or taking antihypertensive medication (INC VI, 1997) . Approximately 50 million Americans have hypertension. Furthermore, heart disease and stroke remain the first and third leading cause of death in the United States, respectively (Burt, 1995) . Controlling elevated blood pressure -whether through lifestyle changes or pharmacologic therapy -reduces an individual's risk of heart disease, heart attack, stroke, and kidney failure (INC VI, 1997) . Clients with uncontrolled high blood pressure often have damage to the heart, kidneys, and eyes and needlessly experience premature disability and death. Occupational health nurses have an enormous public health opportunity to reduce the effects of hypertension on working adults by designing worksite prevention programs that focus on lifestyle modifications, early detection and referral and, in some cases, medication compliance monitoring at the worksite.
The JNC VI report reviews the progress made in the past 25 years through efforts to prevent, detect, and treat high blood pressure. Since 1972, death rates have declined by nearly 60% for stroke and by 53% for coronary heart disease (NHLBI, 1997a) . Awareness, treatment, and control rates for hypertension have increased significantly (Burt, 1995) . Since the inception of the NHBPEP, awareness has increased from 51% to 78%, treatment of persons with hypertension has increased from 31% to 55%, and the number of persons with high blood pressure controlled to <140/90 mm Hg has increased from 10% to 29%. These impressive gains have been seen in all age groups, in both men and women, and in special populations (Burt, 1995) . However, the JNC VI report also describes some disturbing trends.
After years of decline, the mortality rates for stroke and coronary heart disease may be leveling and possibly increasing (NHLBI, 1997b) . Two community studies have shown that hypertension prevalence may be rising and control rates may be decreasing (Luepker, 1995; Meissner, 1997) . In addition, end stage renal disease (ESRD) and heart failure have become greater burdens on the health care system in the past decade. The incidence of ESRD, for which high blood pressure is the second most common antecedent, has increased threefold and is a growing public health problem (U.S. Renal Data System, 1997). The incidence of heart failure, the most common reason for hospitalization of older Americans, has increased dramatically over the past 2 decades. Nearly all clients with heart failure have antecedent hypertension (Levy, 1996) . These are important signals, and the INC VI report needs to be viewed as a call for action.
HIGHLIGHTS OF INTEREST TOTHE OCCUPATIONAL HEALTH NURSE
Blood Pressure Goals and Stages
Goal blood pressure for most patients is systolic blood pressure <140 mm Hg and diastolic blood pressure <90 mm Hg. Lower goals are recommended for people with diabetes 030/85) or renal insufficiency 025/75) and for some other special populations and situations. In the classification of blood pressure levels, stage 3 and stage 4 hypertension are now combined into one category -stage 3 (see Table) .
Prevention and Control
According to INC VI, the most effective lifestyle changes for preventing and controlling high blood pressure are: • Lose weight if overweight, • Increase aerobic physical activity to 30 to 45 minutes on most days of the week, • Maintain a healthy diet the DASH [Dietary Approaches to Stop Hypertension] diet is specifically recommended (INC VI, Appendix A 1997), • Reduce daily sodium intake to no more than 100 millimoles per day (2.4 grams sodium or 6 grams sodium chloride) which is about 1 tsp. of salt, • Limit alcoholic intake to no more than 1 ounce of ethanol per day for men (for example, 24 ounces of beer, 10 oz. of wine, or 2 oz. of 100-proof whiskey) or Y2 oz. ethanol per day for women and lighter weight people, • Eat enough foods with potassium, such as bananas, orange juice, potatoes, yogurt, and prunes. Daily potassium intake should be at least 90 millimoles, or 3.5 grams, • Stop smoking and reduce dietary saturated fat and cholesterol, and • For clients who have not been able to prevent or control high blood pressure after a concerted effort to change lifestyle, drug therapy should be started.
Treatment
The following highlights of the treatment recommendation represent the ideal or "Gold Standard" for hypertension management, but may as yet, not be consistently practiced. Occupational health nurses need to be aware of these recommendations and assist hypertensive employees to navigate their health insurance and primary care options to best meet their needs.
INC VI advises stratifying clients with hypertension VI, NIH Publication No. 98-4080, November, 1997. by blood pressure stage 0, 2, and 3) and into risk groupings (A, B, and C) to guide treatment decisions. These groups are based not only on blood pressure level but also on the presence of other risk factors such as high blood cholesterol, organ damage, smoking, dyslipidemia, and diabetes. For example, an individual in Risk Group A with stage 1 hypertension (systolic blod pressure 140-159 mm Hg and diastolic blood pressure 90-99 rom Hg) with no cardiovascular disease, organ damage, or other risk factors tries lifestyle changes for 1 year before taking drugs. In contrast, the earlier guidelines suggested that such individuals should try lifestyle changes for only 3 to 6 months before starting medication. A Table is included that can be used by clinicians to determine risk stratification and treatment. The report recommends diuretics and beta-blockers as the first line of treatment for uncomplicated hyperten-sion. Other drugs, sometimes combined with diuretics or beta-blockers, are available to treat clients with complications. In general, INC VI advises that most clients should be started on a low dose of the initial drug, that long acting formulas are usually preferable, and that even if a diuretic is not chosen as the first drug it can be used to enhance the effects of other medications.
For the first time the guidelines establish "compelling indications" for specific drugs when clients have certain clinical conditions. For example, older persons with isolated systolic hypertension should first receive diuretics. Individuals with diabetes, kidney damage, and high blood pressure should begin treatment with ACE inhibitors. Heart attack (along with hypertension) is a compelling indication for prescribing beta-blockers and sometimes ACE inhibitors. Heart failure should first be treated with ACE inhibitors and diuretics.
Strategies clinicians can use to improve the low rate of adherence to therapy are updated and amplified. The cost of drug therapy can interfere with hypertension control. Cost cutting measures include using combination tablets and generic drugs and dividing some types of large tablets, which may be less expensive.
The guidelines repeat earlier warnings from the NHLBI about negative heart effects of a calcium channel blocker called short acting nifedipine. This drug should be used only with great caution, if at all. A section on treating special populations and situations gives recommendations based on clinical trial results since INC V was issued in 1992. Clinical trials in the past 5 years have yielded stronger evidence for the benefit of treating high blood pressure in older persons and persons with heart failure. Lifestyle changes are particularly important for African Americans, who have a high prevalence of heart disease risk factors such as obesity and increased sensitivity to salt. The report indicates diuretics should be the first drug of choice for this population.
WAKE-UP CALL
The INC VI report documents that since 1972 age adjusted death rates from coronary heart disease (CHD) and stroke have declined 53% and nearly 60%, respectively. However, since JNC V was published in 1992, death rates for stroke have risen slightly and death rates for CHD have leveled. Results from a Minnesota study show a decrease in awareness, treatment, and control of hypertension (Luepker, 1995) . The Minnesota data may 116 foreshadow the future. Clinicians must start paying more attention to hypertension detection and treatment. Another example of local data causing concern, is of recent age adjusted data from Iowa which show an increase in average blood pressure (Meissner, 1997) . These trends should be of great concern among occupational health care professionals. INC VI also includes data suggesting that progress in other areas is not as encouraging as expected. The alarming increase in the incidence of end stage renal disease and hospitalizations for heart failure points to the need for better control of high blood pressure in patients at risk for these conditions. To obtain a copy of the iNC VI report contact the NHLBIInfonnation Center, P.O. Box 30105, Bethesda, MD 20824-0105, call (301) 251-1222 , fax (301) 251-1223 To provide feedback or report on innovative worksite hypertension programs, contact Pamela V. Moore, EdD, MPH, RN, Managing Editor, AAOHN Journal, 6900 Grove Rd., Thorofare, Ni 08086, 
